ADK and schizophrenia: In animal models of schizophrenia-like behaviors, augmenting adenosine levels in mice that overexpress the enzyme ADK [37] and antagonism of the P2X7R in the sub-chronic phencyclidine-induced model of schizophrenia [144], significantly improved cognitive deficits.